BioPharma Pharma Research

Sirnaomics Completes Phase I Clinical Study of STP707 for Pancreatic Cancer with Strong Safety Profile and Promising Disease Stability

Sirnaomics , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, today announced that the Group h...

 July 01, 2024 | News

Huadong Medicine Announces Positive Phase I Clinical Trial Results for Oral GLP-1 Receptor Agonist HDM1002 in China

HUADONG MEDICINE, through its wholly-owned subsidiary Hangzhou Zhongmei HuaDong Pharmaceutical CO. LTD (Zhongmei HuaDong), has recently announced positive ...

 June 27, 2024 | News

South Korea Approves Reimbursement for Antengene's XPOVIO®, Expanding Access to Relapsed/Refractory Multiple Myeloma Treatment

- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treat...

 June 27, 2024 | News

Jubilant Radiopharma Invests $50 Million to Expand PET Radiopharmaceutical Manufacturing Facilities in the U.S.

Jubilant Radiopharma’s Radiopharmacies division is excited to announce an investment of $50 million (USD) to expand its PET radiopharmaceutical manuf...

 June 25, 2024 | News

Merck’s SMCxPRO® Immunoassay Technology Advances Parkinson’s Disease Research Through MJFF Collaboration

SMC® immunoassay technology from Merck detects small changes in biomarker levels, indicating level of cell dysfunction New understanding of cel...

 June 24, 2024 | News

Ascentage Pharma Announces Completion of Equity Investment by Takeda

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related...

 June 21, 2024 | News

ReviR Therapeutics and Asieris Pharmaceuticals Achieve Milestone in Cancer Treatment Collaboration

ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncolog...

 June 18, 2024 | News

Ascentage Pharma Secures $1.3 Billion Deal with Takeda for Global Rights to Olverembatinib

Ascentage Pharma has executed an Exclusive Option to License Global Rights to Olverembatinib worldwide other than China and a few other areas. ...

 June 17, 2024 | News

BeiGene and NewBridge Pharmaceuticals Conclude Partnership to Strengthen BeiGene's Direct Operations in MENA Region

BeiGene , a global oncology company, and NewBridge Pharmaceuticals have jointly decided to conclude their partnership. This strategic decision aligns with ...

 June 14, 2024 | News

Aragen Bioscience and Getinge Validate Single-Use Production Reactors for Large-Scale Recombinant Antibody Production

Aragen Bioscience, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, and Getinge, a Swedish...

 June 05, 2024 | News

South Africa to Bolster Pharmaceutical Sovereignty with Cutting-Edge Biotherapeutic Platform

Technology transfer will strengthen South Africa’s pharmaceutical sovereignty and drastically reduce production costs, thus improving affordability a...

 June 04, 2024 | News

Thermo Fisher Scientific Launches Advanced Solutions to Boost Research Efficiency at ASMS Conference

Thermo Fisher Scientific has introduced new solutions aimed at accelerating research workflows, unveiled at the annual American Society for Mass Spectromet...

 June 04, 2024 | News

Monash University and Thermo Fisher Scientific Forge New Partnership to Propel Scientific Advancements

Marking an exciting new chapter in a long-standing relationship, Monash University has entered into a Memorandum of Understanding with Thermo Fisher Scient...

 May 30, 2024 | News

Metabolon Enhances Metabolomics Services with New Spectral Data Option

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

 May 29, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in